Loss of perlecan heparan sulfate glycosaminoglycans lowers body weight and decreases islet amyloid deposition in human islet amyloid polypeptide transgenic mice.

Saved in:
Bibliographic Details
Title: Loss of perlecan heparan sulfate glycosaminoglycans lowers body weight and decreases islet amyloid deposition in human islet amyloid polypeptide transgenic mice.
Authors: Templin, Andrew T1, templin@uw.edu, Mellati, Mahnaz1, Soininen, Raija2, Hogan, Meghan F1, Esser, Nathalie1, Castillo, J Josh1, Zraika, Sakeneh1, Kahn, Steven E1, Hull, Rebecca L1
Source: PEDS: Protein Engineering, Design & Selection; Feb2019, Vol. 32 Issue 2, p95-102, 8p
Database: Applied Science & Technology Source
Full text is not displayed to guests.
Description
ISSN:17410126
DOI:10.1093/protein/gzz041